Metoclopramide-induced parkinsonism due to bilateral basal ganglia and brain stem involvement in a patient with laryngeal carcinoma
Ali İnal 1 * , Ertugrul Uzar, Muhammed Ali Kaplan, Mehmet Küçüköner, Zuhat Urakcı, Faysal Ekici, Abdurrahman Işıkdoğan
More Detail
1 Dicle Üniversitesi Tıp Fakültesi Tıbbi Onkoloji kliniği, Diyarbakır, Turkey* Corresponding Author


A 52-year-old male patient with laryngeal carcinoma was treated with docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy. Because of severe nausea and vomiting 15 days after the first course of chemotherapy, metoclopramide was administered. Parkinsonism symptoms were observed on the 6th day of metoclopramide therapy. Cerebral MRI revealed bilateral basal ganglia and brain stem involvement. Metoclopramide therapy was promptly discontinued and oral biperiden was commenced. Parkinsonism findings almost completely improved on his control examination performed after one month. He was not given metoclopramide during further chemotherapy courses. Cerebral MRI taken after three months revealed that the lesions have completely relieved.
This is an extremely rare case of metoclopramide-induced parkinsonism together with brain stem and basal ganglion involvement in a patient with laryngeal carcinoma treated by chemotherapy. The clinical and radiological improvement was observed with the cessation of the causative drug and biperiden therapy.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

J Clin Exp Invest, 2012, Volume 3, Issue 4, 536-538

Publication date: 13 Dec 2012

Article Views: 2251

Article Downloads: 1157

Open Access References How to cite this article